BackChina Dasheng Biotechnology Company Overview

China Dasheng Biotechnology Company Long Term Debt

China Dasheng Biotechnology Company's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

China Dasheng Biotechnology Company Long Term Debt History

Loading

China Dasheng Biotechnology Company vs. peers: Long Term Debt Comparison

Loading

China Dasheng Biotechnology Company Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

China Dasheng Biotechnology Company (CDBT) FAQ

The latest long-term debt for CDBT is $0 as of March 2026. Investors often review this figure alongside China Dasheng Biotechnology Company's historical trend and sector peers before judging valuation or financial health.

A long-term debt figure of $0 for CDBT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CDBT's long-term debt ($0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.